Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate-specific antigen and screening for prostate cancer.

Misop Han1, Peter H Gann, William J Catalona

  • 1Department of Urology, Feinberg School of Medicine, Northwestern University, 675 North St. Clair Street, Suite 20-150, Chicago, IL 60611, USA.

The Medical Clinics of North America
|March 31, 2004
PubMed
Summary

Prostate-specific antigen (PSA) testing aids in prostate cancer screening. This review covers PSA

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in Industry-Sponsored Research Payments to Otolaryngologist Principal Investigators.

The Laryngoscope·2026
Same author

Trends in Industry-sponsored Research Payments to Anesthesiologist Principal Investigators.

Anesthesiology·2026
Same author

A trial of risk-adapted prostate cancer screening in a federally supported health center network serving a high-risk population.

Cancer·2026
Same author

Trends in Industry-Sponsored Research Payments and General Payments to Neurologists: Open Payments Program 2015-2023.

Neurology. Clinical practice·2026
Same author

Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs Mutation.

The Prostate·2026
Same author

Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells.

Science advances·2026

Area of Science:

  • Oncology
  • Urology
  • Biochemistry

Background:

  • Prostate-specific antigen (PSA) is a protein produced by cells of the prostate gland.
  • Elevated PSA levels in the blood can indicate prostate cancer, but also benign conditions.
  • PSA testing has become a cornerstone of prostate cancer screening strategies worldwide.

Purpose of the Study:

  • To provide a comprehensive overview of prostate-specific antigen (PSA) testing in the context of prostate cancer screening.
  • To explore the historical development, biological basis, and clinical applications of PSA testing.
  • To discuss methods for enhancing PSA test accuracy and the ongoing controversies surrounding its use.

Main Methods:

  • Literature review of studies on PSA biology, testing, and prostate cancer screening.

Related Experiment Videos

  • Analysis of historical data and clinical guidelines related to PSA testing.
  • Discussion of scientific literature addressing controversies and future directions in PSA screening.

    • Main Results:

    • PSA is a key biomarker for prostate cancer detection.
    • PSA testing has evolved significantly, with ongoing efforts to improve its accuracy.
    • Significant debates persist regarding the optimal use and interpretation of PSA screening, particularly concerning overdiagnosis and overtreatment.

    Conclusions:

    • PSA testing remains a valuable tool in prostate cancer management, but requires careful interpretation.
    • Improving PSA test accuracy and understanding its limitations are crucial for informed clinical decision-making.
    • Balancing the benefits of early detection with the risks of overdiagnosis is central to the prostate cancer screening controversy.